Temodar and Sutent as Therapy for Melanoma

NCT00304200 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Funding was inadequate to continue; Companies requested closure.

Conditions

Metastatic Malignant Melanoma

Interventions

DRUG: Temozolomide and SU11248

Sponsor

Northern California Melanoma Center

Collaborators

[object Object]
[object Object]